ARIELLE DEASEL: Open Payments
NPI 1013581974 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 34 payments from 16 companies in 2025. Trend: 2023 $506 · 2024 $383 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $166 |
| Novo Nordisk Inc | 8 | $148 |
| Lilly USA, LLC | 4 | $70 |
| PFIZER INC. | 3 | $58 |
| Dynavax Technologies Corporation | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $28 |
Products named: AIRSUPRA, Ozempic, Heplisav-B, MOUNJARO, Kerendia, JARDIANCE, Rybelsus, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
